Jay Johnson and the LSU Tigers continue navigating a pivotal stretch this offseason with the 2025 MLB Draft in the rearview mirror. After seeing multiple signee ...

Speaker Mike Johnson (R-La.) is seeking to close the distance between himself and President Trump when it comes to the release of the government’s files on Jeffrey Epstein, the late pedophile ...

Johnson & Johnson shares surged Wednesday after the company reported second-quarter results that topped estimates and the company lifted its full-year outlook.

Johnson & Johnson (NYSE:JNJ) on Wednesday reported a second-quarter 2025 adjusted earnings of $2.77 per share, down 1.8% year ...

Illinois Comptroller Susana Mendoza said Wednesday she’ll give up her statewide office as she considers her “next biggest ...

Adjusted earnings per share for the quarter to June 29 fell to $2.77 from $2.82 in the same period a year ago, and topped the ...

Johnson & Johnson boosted its full-year outlook as it posted better-than-expected profit and sales in the second quarter.

Johnson & Johnson shows steady growth in Q2, driven by medtech and oncology, yet talc litigation overshadows. Click for my ...

The company reports adjusted earnings of $2.77 a share for the second quarter, beating analysts’ estimates of $2.68.

(Reuters) - Johnson & Johnson reported second-quarter profit and raised its full-year sales forecast by around $2 billion on ...

Johnson & Johnson is leading the S&P 500 and the Dow Jones Industrial Average after the drugmaker slashed its estimate for the impact of tariffs in 2025 and raised its outlook. The company’s stock is ...

J&J reported second quarter earnings Tuesday. The company is under scrutiny by investors as it faces drug patent cliffs.